Waltham, MA, United States of America

Nicole Danielle Bartolo

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Nicole Danielle Bartolo

Introduction

Nicole Danielle Bartolo is an accomplished inventor based in Waltham, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative conjugates for cancer treatment. With a total of 2 patents to her name, Bartolo is recognized for her expertise and dedication to advancing medical science.

Latest Patents

Bartolo's latest patents include "Conjugates comprising cleavable beta-glucuronide-containing linkers" and "Conjugates comprising cleavable linkers." The first patent relates to conjugates that include a specific linker formula and pharmaceutically acceptable salts. This invention is particularly relevant for the treatment of diseases such as cancer, providing new avenues for therapeutic interventions. The second patent also focuses on conjugates with a different linker formula, emphasizing their utility in treating cancer and the synthesis of these conjugates.

Career Highlights

Nicole Bartolo is currently employed at AstraZeneca AB, where she continues to innovate and contribute to the pharmaceutical industry. Her work is characterized by a commitment to developing effective treatments that can improve patient outcomes.

Collaborations

Throughout her career, Bartolo has collaborated with notable colleagues, including Akbar Husain Khan and Andreas Lothar Severino Maderna. These collaborations have further enriched her research and development efforts.

Conclusion

Nicole Danielle Bartolo is a prominent inventor whose work in pharmaceutical innovations is paving the way for new cancer treatments. Her contributions are vital to the ongoing advancements in medical science, and her patents reflect her commitment to improving healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…